Date Title Description PDF
14 Mar 2022 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A. Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download

Pages

Date Title Description PDF
05 Apr 2022 Liquidity and counterparty agreements The Company communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A.  Download
29 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted on 28 March 2022 and end of the share buyback program Download
28 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 21 March 2022 and 25 March 2022 Download
21 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 14 March 2022 and 18 March 2022 Download
14 Mar 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 7 March 2022 and 11 March 2022 Download

Pages

Date Title Description PDF
07 Nov 2019 Information on P&L ROVI releases the first nine months 2019 results presentation Download
03 Oct 2019 Liquidity contracts and specialists Liquidity contract: transactions conducted in the third quarter of 2019 Download
05 Sep 2019 Others on business performance and financial information The Company informs about the construction of a second heparin plant in Granada Download
30 Jul 2019 Information on P&L ROVI releases the first half 2019 results presentation Download
30 Jul 2019 Information on P&L ROVI releases the press release related to the first half 2019 financial results Download

Pages